Updates from Berlin: New Developments in Huntington’s Disease Feb. 2017
Multiple Sclerosis @Point of Care app with Dr. Watson Dec. 2016
Michael J. Fox Foundation (MJFF) Parkinsons' progress Dec. 2016
Regular intake of grapes may protect against early memory decline linked to Alzheimer's disease Feb. 2017
In Search of the Guiding Light: Revisiting the Use of Oral and High-efficacy Therapies in a Modern Era of Multiple Sclerosis Treatment
Pre-activity question 1 of 4
A 32-year-old woman diagnosed with
multiple sclerosis (MS) is well controlled on interferon beta-1a and
would like to be switched to oral medications. Which advice would be
most appropriate to give her?
-
Patients who are well controlled on injectable drugs but switch to oral therapies are not at greater risk of early relapse.
-
The rate of first relapse is much greater in the first 6 months when switching from injectable to oral medications.
-
Disability progression is greater in the first 6 months when switching from injectable to oral medications.
-
Oral medications are ineffective unless combined with injectable medicatio
No comments:
Post a Comment